In this study, we constructed predictive models for MTM-HCC based on clinical characteristics and CECT image findings, confirming high serum AFP, high hemoglobin, tumors without enhancing capsules, and intratumor hypoenhancement (for more than 20% of the whole tumor) were independent predictors for MTM-HCCs. The gene discussed is AFP; the disease is hepatocellular carcinoma.